Managing the adverse events of immune checkpoint inhibitors

Management of immune-related AEs during ICI therapy in the clinicПодробнее

Management of immune-related AEs during ICI therapy in the clinic

The Role of Immune Checkpoint Inhibitors in Bladder CancerПодробнее

The Role of Immune Checkpoint Inhibitors in Bladder Cancer

Incorporating New IO Therapies - Managing Patient Side EffectsПодробнее

Incorporating New IO Therapies - Managing Patient Side Effects

Managing immune-related adverse events in adjuvant immunotherapyПодробнее

Managing immune-related adverse events in adjuvant immunotherapy

Managing Adverse Events Associated With ICI Combinations in Patients With Unresectable HCCПодробнее

Managing Adverse Events Associated With ICI Combinations in Patients With Unresectable HCC

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by ... | RTCL.TVПодробнее

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by ... | RTCL.TV

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by ... | RTCL.TVПодробнее

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by ... | RTCL.TV

Immune Checkpoint Inhibitors In Renal Cell CarcinomaПодробнее

Immune Checkpoint Inhibitors In Renal Cell Carcinoma

Managing skin toxicities during immune checkpoint inhibitor therapyПодробнее

Managing skin toxicities during immune checkpoint inhibitor therapy

GU Podcast (2020): Immune Checkpoint Inhibitors In RCCПодробнее

GU Podcast (2020): Immune Checkpoint Inhibitors In RCC

Immune Related Adverse EventsПодробнее

Immune Related Adverse Events

Immunotherapy Advances in HNSCC: Expert Update on Treatment Strategies | CMEПодробнее

Immunotherapy Advances in HNSCC: Expert Update on Treatment Strategies | CME

Recognizing and Treating Common Immune-Related Adverse EventsПодробнее

Recognizing and Treating Common Immune-Related Adverse Events

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable MelanomaПодробнее

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Dr Sun on Managing TEAEs of Tisotumab Vedotin in Recurrent/Metastatic HSNCCПодробнее

Dr Sun on Managing TEAEs of Tisotumab Vedotin in Recurrent/Metastatic HSNCC

Guidelines: Management of Immune-Related Adverse EventsПодробнее

Guidelines: Management of Immune-Related Adverse Events

Management of Toxicity of Immunotherapy SessionПодробнее

Management of Toxicity of Immunotherapy Session

Candid Conversations on Modern Urothelial Cancer ManagementПодробнее

Candid Conversations on Modern Urothelial Cancer Management

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by ... | RTCL.TVПодробнее

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by ... | RTCL.TV

Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy ConsiderationsПодробнее

Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy Considerations